Observational 24‐week study to assess clinical response to upadacitinib posttrial in patients with moderate‐to‐severe atopic dermatitis

• Main Authors: Ana Batalla (Author), Hae Jin Suh‐Oh (Author), Gregorio Carretero Hernández (Author), Javier Miquel‐Miquel (Author), Rafael Botella‐Estrada (Author), Antonio Martorell‐Calatayud (Author), Virginia Sanz‐Motilva (Author), Ignasi Figueras‐Nart (Author), Angeles Flórez (Author)
• פורמט: ספר
• יצא לאור: Wiley, 2023-09-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Abstract Background The oral anti‐janus kinase 1 inhibitor upadacitinib has shown a good efficacy-safety profile in the treatment of moderate‐to‐severe atopic dermatitis (AD) in clinical trials; however, few data from real clinical practice have been published so far. Objectives To evaluate the effi...